Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-alpha signaling complex

Oncogene. 2003 Jun 5;22(23):3598-607. doi: 10.1038/sj.onc.1206512.

Abstract

We have previously demonstrated that the responsiveness of multiple myeloma (MM) cells to interferon-alpha (IFN-alpha) stimulation is variable, with an atypical growth response displayed by some cells. Here we report the ability of IFN-alpha to induce tyrosine phosphorylation of a 180 kDa band in the KAS-6/1 MM cell line, which is growth responsive to IFN-alpha. Further characterization demonstrated that this band corresponds to ErbB3. To our knowledge, this is the first report of ErbB3 expression in a cell type of the hematopoietic lineage. Although ErbB receptors have been shown to crosscommunicate with various other receptors, our results show for the first time that the IFN-alpha receptor can crosscommunicate with ErbB3. To address the significance of these observations, we transfected ErbB3-negative DP-6 MM cells with ErbB3 and used siRNA to silence ErbB3 in the KAS-6/1 cell line. Although IFN-alpha transactivated ErbB3 in the DP-6 transfectants, it did not confer growth responsiveness to IFN-alpha. Interestingly, silencing ErbB3 expression in the KAS-6/1 cells decreased the overall growth response to IFN-alpha and to interleukin-6. These results suggest that ErbB3 expression alone does not uniquely confer IFN-alpha growth responsiveness, but instead may amplify proliferation rates in MM cells that have acquired atypical expression of this receptor.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Division / drug effects
  • DNA-Binding Proteins / drug effects
  • DNA-Binding Proteins / metabolism
  • Down-Regulation
  • Enzyme Activation / drug effects
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Interferon-alpha / metabolism*
  • Interferon-alpha / pharmacology
  • Kinetics
  • Macromolecular Substances
  • Mitogen-Activated Protein Kinases / drug effects
  • Mitogen-Activated Protein Kinases / metabolism
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / genetics
  • Multiple Myeloma / metabolism*
  • Phosphorylation / drug effects
  • RNA, Small Interfering / pharmacology
  • Receptor Cross-Talk / physiology*
  • Receptor, ErbB-3 / drug effects
  • Receptor, ErbB-3 / genetics
  • Receptor, ErbB-3 / metabolism*
  • Receptor, Interferon alpha-beta
  • Receptors, Interferon / metabolism
  • STAT3 Transcription Factor
  • Signal Transduction
  • Trans-Activators / drug effects
  • Trans-Activators / metabolism
  • Tumor Cells, Cultured
  • Tyrosine / metabolism

Substances

  • DNA-Binding Proteins
  • Interferon-alpha
  • Macromolecular Substances
  • RNA, Small Interfering
  • Receptors, Interferon
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Trans-Activators
  • Receptor, Interferon alpha-beta
  • Tyrosine
  • Receptor, ErbB-3
  • Mitogen-Activated Protein Kinases